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Abstract: Background: Community pharmacists are involved in antimicrobial stewardship through
self-care advice and delivering medications for uncomplicated infections. Objectives: This mixed
methods study aimed to identify opportunities to enhance the role of community pharmacists in the
management of service users with suspected or confirmed urinary tract infection (UTI). Methods: Data
collection was through a service user survey (n = 51) and pharmacist surveys and semi-structured
interviews before (16 interviews, 22 questionnaires) and after (15 interviews, 16 questionnaires) trialing
UTI leaflets designed to be shared with service users. Data were analysed inductively using thematic
analysis and descriptive tabulation of quantitative data. Results: Twenty-five percent (n = 13/51) of
service users with urinary symptoms sought help from a pharmacist first and 65% (n = 33/51) were
comfortable discussing their urinary symptoms with a pharmacist in a private space. Community
pharmacists were confident as the first professional contact for service users with uncomplicated UTI
(n = 13/16, 81%), but indicated the lack of a specific patient referral pathway (n = 16/16, 100%), the
need for additional funding and staff (n = 10/16, 62%), and the importance of developing prescription
options for pharmacists (5/16, 31%). All community pharmacists reported playing a daily role in
controlling antimicrobial resistance by educating service users about viral and bacterial infections and
promoting a healthy lifestyle. Enhancing their role will need greater integrated working with general
practices and more prescribers based in community pharmacy. Conclusion: This study suggests that
community pharmacists could play a greater role in the management of uncomplicated UTI. The
current reconfiguration of primary care in England with primary care networks and integrated care
systems could provide a real opportunity for this collaborative working with potential learning for
international initiatives.
Keywords: pharmacist; community; urinary tract infections; leaflet; self-care; general public
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1. Introduction
Urinary tract infections (UTIs) are one of the most commonly seen bacterial infection in general
practice. Up to 50% of women will have a UTI in their lifetime and 30% among them will have
recurring episodes [1,2]. Outcomes are usually very good as most cases resolve in 3–4 days without
complications with empiric antibiotics [3]. Of all the antibiotics prescribed in primary care, 15–20% are
prescribed for UTIs [4]. However, as many as 60% of women with suspected UTIs have a urine culture
negative for bacteria and may not need antibiotics [5]. The prevalence of inappropriate antibiotic
prescribing for UTI in primary care may be over 70% [6]. However, UTIs account for around 20% of
community-acquired bacteraemia in patients admitted to an English National Health Service (NHS)
Trust in 2007–08 and studies suggest that up to 50% of Escherichia coli bloodstream infections in England
could be owing to urinary tract infections [7,8]. Furthermore, increases in the incidence of Escherichia
coli bloodstream infections in England were mostly driven by community cases [8].
In a recent study, 95% of women consulted a health professional for their most recent UTI: 74%
reported being prescribed an antibiotic, yet only 63% of these reported taking them, highlighting the
need for better advice about antibiotics in the community [9]. Community pharmacists are involved
daily in antimicrobial stewardship (AMS) by providing patients with self-care advice, delivering
medications, and recommending over-the-counter (OTC) treatments for common infections. The
U.K. 2019 5-year antimicrobial resistance (AMR) action plan states that primary care pharmacists
have a critical role in reviewing prescriptions for antimicrobials and challenging those that may
be inappropriate [10]. National and local campaigns advise the general public to first contact their
pharmacist for healthcare advice [9]. Community-based interventions by pharmacists have the potential
to control the rise of bacteraemia and to improve antimicrobial use for UTIs by increasing patient
knowledge and self-care skills. Measures such as enhanced self-care, preventative care, and referral to
general practitioners (GPs) when appropriate could improve the health and wellbeing of the general
public. This is particularly relevant as virtually all service users with suspected or confirmed UTI visit
a community pharmacy either before their GP or after to collect a prescription. Patient group directions
(PGDs) allow healthcare professionals to supply and administer specified medicines to pre-defined
groups of patients, without a prescription [11]. While PGD for patients with uncomplicated UTIs
fulfilling specific criteria allow pharmacists to provide nitrofurantoin, thus improving patient access
to early treatment [12], few guidelines have been developed to guide pharmacists in the community
management of suspected or confirmed UTI. The International Pharmaceutical Federation issued in
2015 a report on the contribution of pharmacists to fight antimicrobial resistance [13]. While most
interventions are targeting hospital pharmacists, some countries have issued policies for community
pharmacists, such as New Zealand or Canada, where community pharmacists can prescribe first-line
antibiotics for uncomplicated UTIs [14,15].
The U.K. national action plan (NAP) for AMR indicates a need to strengthen the links between
primary care pharmacists and GP practices [10], but further research is required to investigate the best
measures to empower pharmacists in AMS roles.
The objective of this study was to explore the views of pharmacy staff and service users on
providing or receiving advice for suspected or confirmed UTIs in the community pharmacy setting.
More specifically, this study aimed to identify opportunities to enhance the role of community
pharmacists in the management of UTI by exploring the journey of service users with urinary symptoms.
2. Methods
2.1. Study Design
This study is part of a trial to implement Public Health England’s (PHE) UTI TARGET leaflets [16]
in community pharmacies (Figure 1). The TARGET UTI leaflets are designed to be shared with service
users to facilitate communication between healthcare professionals and service users and to increase
their confidence on self-care [17]. The leaflets follow relevant National Institute for Health and Care
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Excellence (NICE) guidelines. The study used mixed methods with questionnaires and interviews to
explore the views of pharmacists and service users with suspected or confirmed UTI.
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2.2. Questionnaires and Interviews Schedules
Two semi-struct red questionnaires and interview sc to explore the role of pharmacists in
the prevention a d management of UTIs (before and after trialling the leaflets) and one semi- tructured
questionnaire to analyse the opinion of service users were developed by a multidisciplinary team of
clinicians and researchers at Imperial College London and PHE (Supplementary Materials S1–S6).
The team included doctors specialized in infectious diseases (N.P.S., A.H.), a community pharmacist
(P.P.), a clinical microbiologist (C.M.), and researchers specialized in qualitative methodology and
implementation science (R.A., L.J., D.L., R.Ah.).
The questionnaires were theoretically informed by the Consolidated Framework for
Implementation Research to understand i dividual level and contextual influencing factors to the
adoption of the leaflet [18]. The questionnaires were reviewed and tested by two community
pharmacists a d were refined a cording to comments. The pharma ist questionnaires collected
information about demographics, characteristics of the pharmacies, particularities of giving advice
in the pharmacy setting generally, and specifically about the UTI patient journey, using closed and
open-ended questions. The questionnaire for service users collected information about demographics,
literacy, the service user experience of their suspected UTI, its management, self-care, and resolution.
This was piloted with a service user representative and subsequently revised based on feedback.
Interviews were done by a doctor specialized in infectious diseases.
2.3. Study Setting: Community Pharmacies in Newham
Community pharm cies were ncluded in one Lo don borough (New am), purposively sampled,
which would en ble views from service us rs of different socio-e onomic status. A invitation,
including an information leaflet and consent form, was sent by the local pharmaceutical committee lead
pharmacist to 26 pharmacies in April 2019. Researchers sent non-responders a reminder 2 weeks later.
2.4. Participant Enrolment
Pharmacists agreed to participate in a phone interview and complete an electronic questionnaire
before trialling the TARGET UTI leaflets for 3 months in their pharmacy. At the end of the 3 months,
the pharmacists participated in a second interview and completed a further questionnaire. These
pharmacists were provided with a £30 voucher incentive after each interview. Service users who
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received the TARGET UTI leaflet at the pharmacy were invited to participate in the study in person
when they were given the leaflet to complete a paper or electronic survey at home. The paper survey
with a written consent form was attached to the leaflet in a prepaid envelope and the electronic survey
was accessible via the use of a QR code or a weblink both written on the paper survey. Service users
were provided a £10 voucher incentive if they completed the survey electronically or sent it by mail.
2.5. Data Analysis
The interviews were recorded, anonymized, and transcribed verbatim by a professional company
and checked against the interviews by a researcher. Interviews were analysed by a researcher using
an inductive thematic analysis [19]. Two other authors independently and inductively coded three
different transcripts. The three researchers collectively reviewed and reached a consensus about the
application of themes through independent coding and group discussion, which were then reviewed
and agreed by the research team. The interviews were then coded according to the themes using the
NVivo 12 software. Data from the closed-ended questions of the surveys were imported into the R
software (version 3.2.4). Numerical data were presented as absolute numbers, proportion, median
± interquartile range (IQR). Pearson’s chi-squared tests were used to compare the results among
service users.
2.6. Ethics
The study received approval from Imperial College London and ethics committee [Imperial
College Research Ethics Committee reference: 18IC4777]. Data management was compliant with the
European General Data Protection Regulation.
3. Results
3.1. Participants: Pharmacists and Service Users
Among the 26 pharmacies contacted in Newham, 20 (77%) participated in the pre-intervention
assessment. Among them, 16 pharmacies (62%) participated in the study including the pre-intervention
questionnaire and interview, the 3-month trial of the leaflets, and the post-intervention questionnaire
and interview. Sixteen interviews and 22 questionnaires were completed before and 15 interviews and
16 questionnaires after trialing the leaflet (Figure 1). The median duration of the interviews was 24
min (IQR, 19–27) and 16 min (IQR, 14–17) for the pre- and post-intervention interviews, respectively.
The pharmacist participants comprised 8 women and 14 men, with a median of 15 years (IQR, 5–30)
post qualification experience (Table 1). Fifty-one service users participated in the survey, the majority
of whom were female; 43 (84%). Twenty-one participants (41%) had recurrent UTIs, 23 (45%) had
previously experienced one or two UTIs, and 6 (12%) had a UTI for the first time.
Table 1. Characteristics of the participants. IQR, interquartile range; UTI, urinary tract infection.
Pharmacists n (%) or Median (IQR) (n = 22)
Women 8 (36)
Job description
Non-prescribing pharmacists 18 (82)
Prescribing pharmacists 3 (14)
Pharmacy technician* 1 (4)
Years since qualification 15 (5–30)
Years in the pharmacy 9.5 (5–17)
Pharmacy staff (full time equivalent) in the pharmacy 4 (3–5)
Service users per day 55 (40–100)
Estimated percentage of male service users seen in the pharmacy 61 (52–62)
Service users seen in the consultation room per day 8 (5–12)
Estimated number of service users given healthcare advice 20 (16–37)
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Table 1. Cont.
Service Users n (%) (n = 51)
Women 43 (84)
Age














Recurrent UTIs 21 (41)
One or two prior episodes 23 (45)
No prior episode 6 (12)
* One pharmacy technician was asked by a pharmacist to complete the pre-assessment questionnaire for the
pharmacy, but this participant did not participate in the interviews nor the trial of the leaflets.
3.2. Survey Results: The Patient UTI Journey in the Community
Before seeing a healthcare professional, 15/51 (29%) service users reported consulting their family
and 9/51 (18%) reported consulting online sources (e.g., NHS choices) for information on urinary
symptoms. Younger participants (aged 18–34 years versus those aged over 34 years) were more likely
to access information about UTI on the internet (50% versus 18%) (p = 0.01). Two-thirds (n = 31, 62%) of
the service users reported drinking more fluids before going to the pharmacy or visiting their GP, but 20
(39%) did not. Some service users reported taking paracetamol (n = 15, 29%), cranberry juice or capsules
(n = 12, 24%), resting (n = 10, 20%), cystitis sachets (n = 8, 16%), nonsteroidal anti-inflammatory
drugs (n = 7, 14%), or time off work (n = 2, 4%). Cystitis sachets are popular OTC medications in the
United Kingdom that contain sodium citrate or potassium citrate and could reduce the acidity of urine.
However, there is currently no evidence to support taking cystitis sachets or cranberry products to
improve UTI symptoms. Thirty-seven service users (72%) went to a pharmacy following a GP visit
after being prescribed an antibiotic and 13 (25%) went to a pharmacy before visiting a GP (Figure 2).
The results from the pharmacists’ questionnaires confirmed this finding stating that, on average, 71%
of service users came to the pharmacy following a GP visit with an antibiotic prescription and 29%
visited the pharmacy first for advice and OTC medication. Service users rarely reported (n = 2, 4%)
going to the pharmacy following a GP visit when antibiotics had not been prescribed.
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3.3. Advice in the Pharmacy
During interviews, pharmacists identified barriers and facilitators to providing healthcare advice
in the pharmacy setting compared with a GP practice (Table 2). The most cited barriers were lack of staff
or time (n = 17, 77%), language barrier (n = 13, 59%), and absence of access to patient medical records
(n = 9, 41%). On the contrary, facilitators were that pharmacists are trained and confident in giving
advice (n = 22, 100%), that no appointment is needed (n = 17, 77%), and that pharmacies have long
opening hours (n = 14, 64%). The language barrier was mitigated by the number of languages spoken
by the pharmacists and their staff: we discussed this point with six pharmacists who all reported the
fluent use of four to six Asian languages in their pharmacy in addition to English.
Table 2. Barriers and facilitators of giving advice in the pharmacy raised during interviews.
Pharmacists n = 22 (%)
Barriers
Lack of time or staff 17 (77)
Language barrier 13 (59)
No access to the medical record 9 (41)
Not recognised or funded by health authorities 5 (23)
No possibilities to prescribe medication 5 (23)
Outside the scope of expertise of pharmacists 3 (14)
Waiting time is unpredictable for servi e users 2 (9)
Some service users prefer information from doctors 2 (9)
Facilitators
Pharmacists are confident and trained in giving advice 22 (100)
No appointment needed 17 (77)
Long opening hours 14 (64)
Ease of access 13 (59)
Multiple languages spoken by the staff 12 (55)
Financial incentive to give additional advice 10 (45)
Availability and use of a consultation room 9 (41)
Close contact with the service users 8 (36)
Flexible time for consultation (no time limit) 6 (27)
Counter assistants and sufficient staff 5 (23)
Local presence/community-based 2 (9)
Possibility to give advice on the phone 2 (9)
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Service users were mostly (n = 33, 65%) comfortable discussing their urinary symptoms with a
pharmacist, as long as it was confidential and in private. As expected, the majority of service users (n
= 36, 70%) did not want to discuss urinary symptoms at the counter if they could be overheard by
other customers.
When asked via questionnaires about the most important self-care advice given to service users
with a suspected UTI, all the pharmacists (n = 22) recommended drinking plenty of fluids and taking
OTC products (e.g., cystitis sachets, cranberry products), 64% (n = 14) recommended painkillers, 36%
(n = 8) discussed red flags to visit the GP, and 27% (n = 6) gave advice regarding preventative care.
All pharmacists who were interviewed agreed that it was difficult to give comprehensive self-care
advice because of the lack of time. Overall, the pharmacists were confident in discussing UTIs with
service users.
3.4. Communication with the GP
During pharmacist interviews, the reasons for referral to the GP were explored (Figure 2). The
pharmacists referred all male patients, pregnant women, older adults (over 65 years old) or children
(below 16 years old), patients with symptoms lasting for more than 48 h, lower abdominal pain or
kidney pain, temperature, blood in the urine or severe comorbidities, and those presenting with
recurrent UTIs to the GP. However, all pharmacist participants pointed out that they did not have a
facilitated way to contact GPs and could only instruct patients to visit their GP:
“So, there’s not much, much of a connection between the two settings. For example, if there
was a patient that we were particularly concerned about, we can’t call up the GP practice
and say, oh, could you give them early appointment because I’ve seen them and I’ve noticed
X, Y, Z. There’s not that rapport yet or there’s not that importance [placed in] a pharmacist’s
view, I feel, in community.” P4.
As such, they stressed the need to develop a special referral pathway between pharmacies and
GPs (n = 16, 100%) and also suggested that the TARGET UTI leaflets could be used as a referral notice
between healthcare professionals.
3.5. The Role of Pharmacists
Table 3 presents the themes and sub-themes that were generated from the qualitative analysis of
the interviews with the pharmacists regarding the management of service users with suspected or
confirmed UTI. Most pharmacists interviewed (n = 13, 81%) suggested that pharmacists could act as a
first-line triage for service users with UTIs:
“Well, I think they [the patients] should come first to the pharmacy ( . . . ) and then you could
screen them and see whether they need to be actually seen by the GP.” P13.
Table 3. Themes and sub-themes of the qualitative analysis of interviews on the role of pharmacists in
the management of service users with suspected or confirmed urinary tract infection. PGD, patient
group direction; NHS, National Health Service; AMR, antimicrobial resistance.
Management of Service Users with Suspected or Confirmed Urinary Tract Infection n (%) (n = 16)
Pharmacists can act as a first-line triage 11 (69)
They need funding or additional staff to do so 10 (62)
They should have more possibilities to prescribe first line treatments (e.g., PGDs) 5 (31)
They can give dipstick tests and check the results 1 (6)
Strengthening the link between pharmacists and GPs
Development of a special referral pathway between pharmacies and GPs 16 (100)
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Table 3. Cont.
Management of Service Users with Suspected or Confirmed Urinary Tract Infection n (%) (n = 16)
Self-care advice relieves pressure on the NHS and the GPs 6 (37)
Reducing the spread of AMR
Education of service users about infections for which antibiotics are not always needed 16 (100)
Screening patients who need to go to the GP 10 (62)
Self-care advice for viral infections and benign bacterial infections 12 (75)
Promotion of a healthy lifestyle 5 (31)
The pharmacists reported that, if they were the first healthcare professional to give advice to
service users with suspected or confirmed UTIs, this could relieve pressure on other NHS services,
including GPs. However, they requested additional funding and staff to give advice for those with
suspected UTI as pharmacies are not currently funded for this. Some also asked for reimbursement for
this activity:
“Yeah, but you see having a role to play is one thing but you need to be remunerated for that
role. You can’t expect pharmacists to do everything for nothing” P13.
Increasing the patient group directions (PGDs) to prescribe first-line treatments for uncomplicated
UTIs could help enhance this role:
“[Having a UTI PGD] . . . could be something which might take a bit of work off the GPs.
And in that service, we do get a consultation fee as well and we do that service for Pharmacy
First or the Minor Ailment. So, I think that’s some revenue, it works for the GP and it works
for the patient” P3.
All the pharmacists interviewed (n = 16, 100%) agreed that they had a major role in the control of
AMR by educating service users about antibiotics and infections for which antibiotics are not needed.
They reported giving daily self-care advice for viral infections and self-limiting UTIs, and triaging
patients and advising when they should consult a GP. They also described having an important role
in preventative measures in community care and participating in preventing bacterial infections by
promoting a healthy lifestyle:
“That is where it should all start. We [pharmacy staff] should be highly focused on prevention,
and providing advice for people to self-care and self-manage, and improve their health. And
that will stop, forget the resistance [AMR], you will not even need to prescribe antibiotics if
people are living a healthy lifestyle. ( . . . ) So, the biggest impact the pharmacist can make is
in the prevention agenda” P10.
4. Discussion
4.1. Summary
We explored the UTI patient journey with both pharmacists and service users to identify
opportunities to enhance the role of community pharmacists specifically in the management of UTIs.
The self-care management of service users with suspected UTI can still be improved as 38% of service
users did not report drinking plenty of fluids before seeing a healthcare professional. One-fourth
of service users with suspected UTI sought help first from a pharmacy, but the majority visited the
pharmacy to pick up their antibiotic prescription after a visit to the GP. Barriers to giving advice in
the pharmacy were the lack of staff or time, the language barrier, and the absence of access to patient
medical records. Pharmacists were trained and confident to give advice to patients with suspected
UTIs, but they pointed out the lack of a specific pathway to refer patients who need an antibiotic
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to GPs. Furthermore, they raised the need for additional funding and staff to enable an increased
role of community pharmacists in the management of uncomplicated UTIs. Community pharmacists
integrated their role to fight AMR into the wider context of healthcare education and promotion of a
healthy lifestyle.
4.2. Comparison with Existing Literature
The proportion of service users with urinary symptoms coming first to a pharmacy (25%) is
close to what has been found in another study, in which 36% of the patients presented directly to
a pharmacy [12]. In a household survey conducted in 2014 in England, only 13% of females who
had ever had a UTI reported going first to a pharmacy. The rate in this study may have been lower
as it included a wide age range of participants [9]. As described in recent studies, this study found
support from both patients and pharmacists for increased access to UTI management and advice
through community pharmacies [12,20]. This confirms the need for interventions targeting community
pharmacies to improve the UTI patient journey including self-care advice and appropriate referral.
According to this study and the literature, the development of a PGD for uncomplicated UTIs is
supported by pharmacists in order to extend their management options [12]. A recent study found
that a community pharmacy-led UTI test-and-treat service for women aged 16–64 years with urinary
symptoms helped to support the appropriate use of antibiotics and reduced demand on other NHS
resources such as GP surgeries.20 However, there is a need to carefully consider the advantages of
PGDs, which should lead to more timely treatment of UTI with the potential drawback of increased
use of antibiotics in UTIs, as has been found for chloramphenicol and eye infections [21]. The risk
of overuse of antibiotics for suspected UTIs leading to increased AMR could be mitigated with an
increased pharmacy access to clear protocols, accurate point-of-care testing [20], urine culture, and
shared patients records [22]. Sixty-two percent of the service users in this study took extra fluids
before consulting a healthcare professional, as compared with 35% in a study in 2014 in the United
Kingdom [9]. This might reflect the effect of recent interventions including online campaigns to
promote self-care of UTIs in the community [23,24].
The barriers to giving self-care advice about UTI in the community pharmacy setting confirm
findings in a qualitative study with GPs, pharmacists, pharmacy staff, and representatives from
pharmacy organisations in England and Wales [22]. Clinicians reported that lack of time or staff and
lack of access to medical information were perceived as barriers to giving effective and thorough
self-care advice. Overall, this study supports increasing the collaboration between GPs and community
pharmacists as advocated in a joint statement by the Royal College of General Practitioners (RCGP)
and the Royal Pharmaceutical Society (RPS) [25]. The proposals of this statement include many
of the measures that have been asked for by pharmacists in this study such as a greater role for
community pharmacy in managing minor conditions, access to health records, and better links between
practice-based pharmacists (clinical pharmacists) and community pharmacy. This has also been
highlighted in the community pharmacy 2019 to 2024 contractual framework that encourages the
development of point-of-care testing in community pharmacies to support efforts to tackle AMR [26].
4.3. Strengths and Limitations
The acceptance rate by community pharmacies to participate was high, and we collected
information from both pharmacists and service users’ point of views, facilitating triangulation
of data. Although patients from white ethnicity were over-represented in the user responses (53%
in this sample versus 28% in the borough according to the 2019 Greater London Authority (GLA)
housing-led projection), this sample of service users did have participants representing the diversity
of Newham borough. Participants’ age was similar to the local population as a whole. Service user
questionnaire completion was quite low, as only 13% of 400 questionnaires were returned. However,
this return rate is quite usual in any service evaluation by the public and the BAME (Black, Asian,
and Minority Ethnic) populations in research are known to be hard to engage [27]. A large part of
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the participants had recurrent UTIs (41%), which might be explained by an increased willingness
of these patients to answer to questionnaires on UTIs. This population of patients could be more
informed than the general population of patients with UTI, however, we still found in this study a
large proportion of participants, including patients with recurrent UTIs, who did not report applying
the standard self-care advice such as drinking plenty of fluids before seeing a healthcare professional.
The small sample size, including 22 pharmacists and 51 patients, as well as the risk of recruitment
bias when recruiting pharmacists or service users motivated to participate in a study, are recognised.
However, qualitative research aims to attain a range of views rather than necessarily obtaining views
representative of the general population. In order to strengthen the results of this study, we have
planned with PHE to extend the trial of the leaflets in a rural area and to include interviews with service
users. The answers obtained in this study may not easily translate to other countries that do not have a
government-sponsored universal healthcare system. Indeed, patients in the United Kingdom have
free access to the NHS, which may encourage them to visit their GP instead of going to a community
pharmacy. Interviewing GPs may also have provided a more comprehensive scope and additional
review regarding the role and value of community pharmacists in AMS for UTIs, but this has already
been attained in other qualitative studies [17,22].
4.4. Implications for Practice
Prescription options for pharmacists, levels of funding, and incentives are areas to explore in policy
and contractual developments. Developing a referral pathway is a way to strengthen the link between
pharmacists and GPs and to give more importance to the place of pharmacists in the community setting.
The referral of patients from pharmacy to GPs could be improved through the use of the TARGET UTI
leaflets that highlight the management of patients with suspected UTI [28]. These results also provide
evidence for the deployment of clinical pharmacists working in GP surgeries as they can represent a
key link to community pharmacists [10] as part of the UK NHS long-term plan for better integration
of care [29]. Primary care networks (PCNs) link the local community and community-based health
and social care providers, including pharmacies, with constituent GP practices at its core [30]. PCNs
intend to make greater use of community pharmacists’ skills and opportunities to engage service
users for integrated out-of-hospital care. Expanding the current test and treat programs for UTIs
in community pharmacies by strengthening PGDs could be an interesting approach to increase the
role of pharmacists. Indeed, in many countries, and particularly low- and middle-income countries,
antibiotics are prescribed by community pharmacies without legal and regulatory framework, which
could increase inappropriate prescriptions [31]. In some of these countries where access to a doctor is
sometimes difficult, supporting and regulating these prescriptions by pharmacists could be a solution
to consider. The results of this study, if confirmed, could inform the writing of guidelines for the
management of service users with suspected or confirmed UTI in community pharmacies and inspire
future strategies and interventions in the community.
5. Conclusions
We identified opportunities and potential interventions to improve the management of service
users with suspected or confirmed UTI in community pharmacies. The current reconfiguration of
primary care in England with primary care networks and integrated care systems could provide a real
opportunity for this collaborative working with potential learning for international initiatives.
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